To be as brave as the people we help.
Read how the 2014 Awards program has captured the interest of numerous organizations around the world.
Lumena is an excellent strategic fit that will enhance Shire’s commitment to patients with life-altering conditions and the Company’s rare disease portfolio and GI business unit.View the Press Release
Shire opposes the misuse, abuse, and diversion of prescription ADHD medicines.
Read more here
ShireTrials.com serves as the source for Shire-sponsored clinical trials, as well as a resource for education and awareness about clinical research. It also provides increased transparency into Shire’s data sharing practices.
We are focused on growing Shire by developing and marketing innovative specialty medicines that address significant unmet patient needs.
View our Annual Report
Download our Annual Report 2013 (PDF)
Shire has a wide range of products on the market and will ensure that it can make more products available in the future.
We're pleased to announce that we have again been recognized as a constituent of the FTSE4Good Index Series. Read more
What Responsibility means to Shire. Read more here.
Shire Opposes Misuse, Abuse andDiversion of Prescription ADHDMedicines. Read more here.